Get Live Data

Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE
Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally
Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globallyView Video

Latest Share Chat

  2. Share Prices
  3. Glaxosmithkline Share Price
  4. Glaxosmithkline Share Regulatory News
  5. Change of name to GSK plc

Pin to quick picksGlaxosmithkline Regulatory News (GSK)

Glaxosmithkline Information

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,599.00
Bid: 1,594.50
Ask: 1,595.50
Change: -19.00 (-1.17%)
Spread: 1.00 (0.063%)
Open: 1,608.00
High: 1,615.00
Low: 1,575.00
Prev. Close: 1,618.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Change of name to GSK plc

16 May 2022 14:00

RNS Number : 6484L
GlaxoSmithKline PLC
16 May 2022
 

GSK plc(the 'Company')

Change of name to GSK plc

The Company today confirms its name has changed from GlaxoSmithKline plc to GSK plc.

The Company announced the decision to change its name to GSK plc on 27 April 2022 together with its first quarter 2022 results. This change has now taken effect.

The London Stock Exchange and the New York Stock Exchange will reflect the change of name in due course. 

Shareholders should note that their shareholdings will be unaffected by the change of name. Existing share certificates should be retained as they will remain valid for all purposes and no new share certificates will be issued.

The ISINs, SEDOLs, CUSIPs and ticker symbols of the Company's ordinary shares and ADS remain unchanged. The Company's Legal Entity Identifier (LEI) remains 5493000HZTVUYLO1D793.

V A WhyteCompany Secretary

16 May 2022

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CANFLFVFEVIRLIF
8910111213141516
Date   Source Headline
4th Feb 202111:15 amRNSDirector/PDMR Shareholding
3rd Feb 202112:00 pmRNSFinal Results
3rd Feb 20217:00 amRNSGSK/CureVac partner on new mRNA Covid-19 vaccines
1st Feb 20212:04 pmRNSTotal Voting Rights
26th Jan 20214:26 pmRNSDirector/PDMR Shareholding
22nd Jan 20217:00 amRNSFDA approves ViiV Healthcare’s Cabenuva for HIV
20th Jan 20214:00 pmRNSDirector/PDMR Shareholding
20th Jan 20213:50 pmRNSDirector/PDMR Shareholding
20th Jan 20213:02 pmRNSDirector/PDMR Shareholding
19th Jan 20216:02 pmRNSDirector/PDMR Shareholding
15th Jan 20214:00 pmRNSDirector/PDMR Shareholding
15th Jan 20213:14 pmRNSDirector/PDMR Shareholding
13th Jan 20211:45 pmRNSDirector/PDMR Shareholding
11th Jan 202111:05 amRNSDirector/PDMR Shareholding
11th Jan 20219:16 amRNSDirector/PDMR Shareholding
4th Jan 202111:25 amRNSTotal Voting Rights
30th Dec 202011:52 amRNSDirector/PDMR Shareholding
23rd Dec 20202:44 pmRNSDirector/PDMR Shareholding
21st Dec 20207:00 amRNSViiV first long-acting HIV regimen approved in EU
11th Dec 20207:00 amRNSSanofi/ GSK update on COVID vaccine candidate
10th Dec 20205:51 pmRNSDirector/PDMR Shareholding
10th Dec 202011:55 amRNSBlock Listing Application
9th Dec 20203:04 pmRNSDirector/PDMR Shareholding
3rd Dec 20205:53 pmRNSDirector/PDMR Shareholding
1st Dec 20203:00 pmRNSTotal Voting Rights
27th Nov 20202:58 pmRNSGSK publishes provisional 2021 dividend dates
26th Nov 202012:35 pmRNSEMTN Supplementary Prospectus
25th Nov 202010:26 amRNSDirector/PDMR Shareholding
23rd Nov 20208:59 amRNSBlock listing Interim Review
19th Nov 20205:40 pmRNSHolding(s) in Company
17th Nov 20205:48 pmRNSDirector/PDMR Shareholding
12th Nov 20201:00 pmRNSMedicago GSK phase 2/3 study start
11th Nov 20203:08 pmRNSDirector/PDMR Shareholding
11th Nov 202011:13 amRNSDirector/PDMR Shareholding
9th Nov 20207:00 amRNSViiV’s cabotegravir superior for HIV prevention
4th Nov 20205:32 pmRNSDirector/PDMR Shareholding
4th Nov 20204:45 pmRNSDirector/PDMR Shareholding
3rd Nov 20204:09 pmRNSDirector/PDMR Shareholding
3rd Nov 20208:00 amRNSGSK sets new environmental goals
2nd Nov 20205:16 pmRNSDirector/PDMR Shareholding
2nd Nov 20203:59 pmRNSTotal Voting Rights
30th Oct 20205:08 pmRNSHolding(s) in Company
30th Oct 202012:53 pmRNSDirector/PDMR Shareholding
28th Oct 20205:46 pmRNSDirector/PDMR Shareholding
28th Oct 202012:00 pmRNS3rd Quarter Results
28th Oct 20207:00 amRNSSanofi and GSK support COVAX - 200m vaccine doses
22nd Oct 202012:34 pmRNSHolding(s) in Company
16th Oct 202012:18 pmRNSPositive CHMP opinion ViiV long-acting HIV regimen
14th Oct 20203:30 pmRNSDirector/PDMR Shareholding
14th Oct 20203:29 pmRNSDirector/PDMR Shareholding
8910111213141516

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.